Emcure Pharma incorporates new wholly-owned subsidiary Emcure Wellness

Published On 2025-07-06 08:00 GMT   |   Update On 2025-07-06 08:00 GMT
Advertisement

PuneEmcure Pharmaceuticals Limited has announced the incorporation of a new wholly-owned subsidiary named Emcure Wellness Private Limited.

The new entity was officially incorporated on July 3, 2025, in Pune, Maharashtra, following necessary regulatory approvals, the company disclosed in a filing to the stock exchanges.

This development follows Emcure’s earlier announcement in June, wherein the Board of Directors had approved the proposal to set up a subsidiary to manufacture, promote, sell, and distribute pharmaceutical and related products. 

Advertisement

As per the details shared, the proposed authorized share capital of Emcure Wellness Private Limited stands at Rs 10 crore, while the proposed paid-up share capital is Rs 1 lakh. 

In a related move, Medical Dialogues team earlier reported in June that Emcure Pharma had also received board approval to enter into agreement with minority shareholders of Zuventus Healthcare Ltd., one of its subsidiaries, to acquire their shareholding. Following the completion of this transaction, Zuventus will become a wholly owned subsidiary of Emcure.

Read also: Emcure Pharma to acquire remaining stake in arm Zuventus Healthcare

Additionally, in April 2025, Tillomed Laboratories Limited, a subsidiary of Emcure Pharma and a European pharma company, entered into an Asset Purchase Agreement (APA) with UK based Manx Healthcare Limited and its subsidiaries Manx Pharma Ltd and Manx Generics Limited.

Established in 1981, Emcure Pharmaceuticals Ltd. is an Indian pharma company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure is an R&D driven company that develops and manufactures a wide range of differentiated pharmaceutical products designed to improve patient health and well-being across several major therapeutic areas. Emcure is present in 70+ countries globally including Europe and Canada.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News